Altered cholesterol and fatty acid metabolism in Huntington disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Lipidology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jacl.2009.11.003PMID 20802793PMCID PMC2926984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immediate implant placement postextraction without flap elevation.

  2009cited by this paper
• Omega-3 fatty acids and dementia.

  2009cited by this paper
• Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins

  2009cited by this paper
• Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study.

  2009cited by this paper
• Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.

  2009cited by this paper
• Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

  2008cited by this paper
• Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

  2008cited by this paper
• Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives.

  2008cited by this paper
• Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion.

  2008cited by this paper
• Fatty acids and insulin sensitivity

  2008cited by this paper
• Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

  2008cited by this paper
• Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells

  2008cited by this paper
• Metformin therapy in a transgenic mouse model of Huntington's disease.

  2007cited by this paper
• Practice Advisory: Utility of surgical decompression for treatment of diabetic neuropathy: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

  2007cited by this paper
• Ethyl-EPA in Huntington disease—Potentially relevant mechanism of action

  2007cited by this paper
• n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.

  2007cited by this paper
• Tetrabenazine as antichorea therapy in Huntington disease

  2006cited by this paper
• Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?

  2006cited by this paper
• Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles.

  2006cited by this paper
• Palmitoylation of huntingtin by HIP14is essential for its trafficking and function

  2006cited by this paper
• Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.

  2006cited by this paper
• The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system

  2005cited by this paper
• High cholesterol level is essential for myelin membrane growth

  2005cited by this paper
• Is docosahexaenoic acid, an n−3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals

  2005cited by this paper
• Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals.

  2005cited by this paper
• Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington’s disease is not improved by treatment with hypoglycaemic agents

  2005cited by this paper
• Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease

  2005cited by this paper
• Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease.

  2005cited by this paper
• Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats Published, JLR Papers in Press, June 1, 2004. DOI 10.1194/jlr.M400087-JLR200

  2004cited by this paper
• Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.

  2003cited by this paper
• Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats.

  2003cited by this paper
• Inhibition by eicosapentaenoic acid of IL-1beta-induced PGHS-2 expression in human microvascular endothelial cells: involvement of lipoxygenase-derived metabolites and p38 MAPK pathway.

  2003cited by this paper
• Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes

  2002cited by this paper
• HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis.

  2002cited by this paper
• Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.

  2002cited by this paper
• Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

  2002cited by this paper
• Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.

  2000cited by this paper
• 24-hydroxycholesterol is a substrate for hepatic cholesterol 7alpha-hydroxylase (CYP7A).

  2000cited by this paper
• Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study.

  1998cited by this paper
• Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.

  1998cited by this paper
• n-3 fatty acids and serum lipoproteins: animal studies.

  1997cited by this paper
• Inhibition of fatty acid beta-oxidation in rat brain cultured astrocytes exposed to the neurotoxin 3-nitropropionic acid.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: human studies.

  1997cited by this paper
• Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism.

  1997cited by this paper
• Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.

  1996cited by this paper
• Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence

  1994cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Huntington's disease mortality in the United States

  1988cited by this paper
• Ingestion of fish oil or a derived n-3 fatty acid concentrate containing eicosapentaenoic acid (EPA) affects fatty acid compositions of individual phospholipids of rat brain, sciatic nerve and retina.

  1987cited by this paper
• Diabetes mellitus in Huntington disease

  1985cited by this paper
• Huntington's disease—growth of fibroblast cultures in lipid‐deficient medium: A preliminary report

  1977cited by this paper

• Navigating the cholesterol maze: Key insights on use of statins in neurodegenerative disorders

  2026cites this paper
• Integrated blood transcriptomic and metabolomic analyses reveal potential biomarkers associated with residual feed intake in meat ducks

  2026cites this paper
• Proteostasis disruption and lipid dyshomeostasis in neurodegeneration: exploring common druggable targets across sporadic and monogenic disorders

  2025cites this paper
• Brain organoid models of Huntington's disease shift the focus towards neurodevelopment

  2025cites this paper
• Parkinson disease is a fatty acidopathy

  2025cites this paper
• AI-Enhanced Transcriptomic Discovery of Druggable Targets and Repurposed Therapies for Huntington’s Disease

  2025influential citation
• The role of oligodendroglial dysfunction in Huntington's disease

  2025cites this paper
• Fatty Acid Profile in the Liver of Mice with Early- and Late-Onset Forms of Huntington’s Disease

  2025cites this paper
• Differential response of neurons to autophagy modulation in Huntington’s disease

  2025cites this paper
• Mediation Analysis for Sparse and Irregularly Spaced Longitudinal Outcomes with Application to the MrOS Sleep Study

  2025cites this paper
• Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases

  2025cites this paper
• Cerebellar lipid dysregulation in SCA3: A comparative study in patients and mice.

  2025cites this paper
• Lipidomics of Huntington’s Disease: A Comprehensive Review of Current Status and Future Directions

  2025cites this paper
• Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in Caenorhabditis elegans

  2025cites this paper
• Evaluating the efficacy of neurotensin receptor-1 antagonist SR48692 in high-fat diet-induced neurotoxicity in mice: An in vivo study.

  2025cites this paper
• Cross Talks between CNS and CVS Diseases: An Alliance to Annihilate

  2024cites this paper
• Stearoyl-CoA desaturase-1: a potential therapeutic target for neurological disorders

  2024cites this paper
• Lactic acid regulates lipid droplet aggregation through a microglia-neuron axis in neuroinflammation

  2024cites this paper
• Multi-omic analysis of Huntington’s disease reveals a compensatory astrocyte state

  2024cites this paper
• Circadian Interventions in Preclinical Models of Huntington’s Disease: A Narrative Review

  2024cites this paper
• Control of innate immunity and lipid biosynthesis in neurodegeneration

  2024cites this paper
• Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System

  2024cites this paper
• Influence of dietary patterns in the pathophysiology of Huntington's Disease: A literature review

  2024cites this paper
• Mono- and Biallelic Inactivation of Huntingtin Gene in Patient-Specific Induced Pluripotent Stem Cells Reveal HTT Roles in Striatal Development and Neuronal Functions

  2024cites this paper
• Transcriptional and Histone Acetylation Changes Associated with CRE Elements Expose Key Factors Governing the Regulatory Circuit in the Early Stage of Huntington’s Disease Models

  2023cites this paper
• Brain cholesterol homeostasis and its association with neurodegenerative diseases.

  2023cites this paper
• Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases

  2023cites this paper
• Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function.

  2023cites this paper
• Metabolic deregulation associated with aging modulates protein aggregation in the yeast model of Huntington’s disease

  2023cites this paper
• Multi-OMIC analysis of Huntington disease reveals a neuroprotective astrocyte state

  2023cites this paper
• Altered Adipocyte Cell Size Distribution Prior to Weight Loss in the R6/2 Model of Huntington’s Disease

  2023cites this paper
• Integrative Analysis Unveils the Correlation of Aminoacyl-tRNA Biosynthesis Metabolites with the Methylation of the SEPSECS Gene in Huntington’s Disease Brain Tissue

  2023cites this paper
• Uncovering the Lipid Web: Discovering the Multifaceted Roles of Lipids in Human Diseases and Therapeutic Opportunities

  2023cites this paper
• PCSK9 and the nervous system: a no-brainer?

  2023cites this paper
• Deneysel hiperkolesterolemide Atorvastatin ve Lactobacillus acidophilus'un kolesterol metabolizmasına etkisi

  2023cites this paper
• Lipid Mediated Brain Disorders: A Perspective.

  2023cites this paper
• Sphingolipids and impaired hypoxic stress responses in Huntington disease.

  2023cites this paper
• Vitamin B6, B12 and folate modulate deregulated pathways and protein aggregation in yeast model of Huntington disease

  2023cites this paper
• Hepatic mitochondrial NAD+ transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis

  2023cites this paper
• Normal range CAG repeat size variations in the HTT gene are associated with an adverse lipoprotein profile partially mediated by body mass index

  2023cites this paper
• Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models

  2022cites this paper
• Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice

  2022cites this paper
• Association between serum lipid levels over time and risk of Parkinson’s disease

  2022cites this paper
• A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development

  2022cites this paper
• Activity and Stability of Panx1 Channels in Astrocytes and Neuroblastoma Cells Are Enhanced by Cholesterol Depletion

  2022cites this paper
• The synaptic lipidome in health and disease.

  2022cites this paper
• Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect

  2022cites this paper
• Single nuclei RNAseq analysis of HD mouse models and human brain reveals impaired oligodendrocyte maturation and potential role for thiamine metabolism

  2022cites this paper
• Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6/1 mouse model with prospects for early diagnosis and monitoring of the disease

  2022cites this paper
• Assessment of Neurodegenerative Changes in Turkeys Fed Diets with Different Proportions of Arginine and Methionine Relative to Lysine

  2022cites this paper
• The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington’s Disease Model by Acting on the Expression of Carnitine-Related Genes

  2022cites this paper
• Proteomic Analysis of Huntington’s Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets

  2022cites this paper
• Metabolites from the Gut Microbiota and the Role in the Gut-Brain Axis

  2022cites this paper
• Environmental stimulation in Huntington disease patients and animal models.

  2022cites this paper
• The Role of Dietary Lipids in Cognitive Health: Implications for Neurodegenerative Disease

  2022cites this paper
• Free Cholesterol Bioavailability and Atherosclerosis

  2022cites this paper
• Converging evidence in support of omega-3 polyunsaturated fatty acids as a potential therapy for Huntington’s disease symptoms

  2021cites this paper
• Transcriptome analysis reveals sexual disparities in gene expression in rat brain microvessels

  2021cites this paper
• Neurological Disorders: Biochemistry of Drug Resistance and Future Challenges

  2021cites this paper
• Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington’s disease

  2021cites this paper
• Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake.

  2021cites this paper
• Homeostasis of Lipid Metabolism in Disorders of the Brain

  2021cites this paper
• PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases

  2021cites this paper
• Neurotrophins as Key Regulators of Cell Metabolism: Implications for Cholesterol Homeostasis

  2021cites this paper
• Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease.

  2021cites this paper
• Assistance for Folding of Disease-Causing Plasma Membrane Proteins

  2020cites this paper
• Lipids as biomarkers of brain disorders

  2020cites this paper
• Dietary Flavonoids in the Management of Huntington’s Disease: Mechanism and Clinical Perspective

  2020cites this paper
• Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington’s disease

  2020cites this paper
• A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson’s disease

  2020cites this paper
• Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease

  2020cites this paper
• Transcriptome Profiling Reveals Novel Candidate Genes Related to Hippocampal Dysfunction in SREBP-1c Knockout Mice

  2020cites this paper
• Huntington’s Disease and Hypertension: Sorting Out Mixed Messages

  2020cites this paper
• Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues.

  2020cites this paper
• Lipid headgroups alter huntingtin aggregation on membranes.

  2020cites this paper
• Cholesteryl ester levels are elevated in the caudate and putamen of Huntington’s disease patients

  2020cites this paper
• Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington’s disease for participants of varying functional disability: a pilot study

  2020cites this paper
• Novel Candidate Genes Related to Hippocampal Dysfunction

  2020cites this paper
• Cholesterin – Baustein oder Risikofaktor?

  2019cites this paper
• Ageing as a risk factor for neurodegenerative disease

  2019cites this paper
• Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis

  2019influential citation
• Structure of Membrane-Bound Huntingtin Exon 1 Reveals Membrane Interaction and Aggregation Mechanisms.

  2019cites this paper
• Ghrelin‐mediated improvements in the metabolic phenotype in the R6/2 mouse model of Huntington's disease

  2019cites this paper
• Lipid metabolism in Alzheimer's disease.

  2019cites this paper
• Cholesterin – Baustein oder Risikofaktor?

  2019cites this paper
• Hybrid Dual Mode Sensor for Simultaneous Detection of Two Serum Metabolites

  2018cites this paper
• Investigating the molecular mechanisms of Hereditary Spastic Paraplegia neuropathies

  2018cites this paper
• Systems genomics approaches in neurologic disease

  2018cites this paper
• Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer's Disease.

  2018cites this paper
• Extremely low frequency electromagnetic field exposure and restraint stress induce changes on the brain lipid profile of Wistar rats

  2018cites this paper
• Developing an antisense oligonucleotide treatment for Spinocerebellar Ataxia Type 3

  2018cites this paper
• Alteration in Fluidity of Cell Plasma Membrane in Huntington Disease Revealed by Spectral Phasor Analysis

  2018cites this paper
• Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain

  2018cites this paper
• Statin use and delayed onset of Huntington's disease

  2018influential citation
• Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease

  2018influential citation
• Deficiency of sterol regulatory element‐binding protein‐1c induces schizophrenia‐like behavior in mice

  2018cites this paper
• Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing

  2018cites this paper
• Altered Levels of Long NcRNAs Meg3 and Neat1 in Cell And Animal Models Of Huntington’s Disease

  2018cites this paper
• Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model

  2018cites this paper
• Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles

  2018cites this paper